The alarmin functions of high-mobility group proteins

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1799, Issue 1-2, 2010, Pages 157-163

  Yang, De ^a,b   Tewary, Poonam ^b   de la Rosa, Gonzalo ^b   Wei, Feng ^b   Oppenheim, Joost J ^b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Alarmin; Dendritic cells; High mobility group protein; Immune response

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALARMIN; CATHELICIDIN; DEFENSIN; EOSINOPHIL PROTEIN X; GRANULYSIN; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP N1 PROTEIN; HISTAMINE; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LACTOFERRIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PROTEIN S 100; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; DENDRITIC CELL; ENDOTHELIUM CELL; EPITHELIUM CELL; GENETIC TRANSCRIPTION; HOST RESISTANCE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; INFECTION; INFLAMMATION; INNATE IMMUNITY; KERATINOCYTE; MACROPHAGE; MEDIATOR; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TISSUE INJURY;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGEN-PRESENTING CELLS; EXTRACELLULAR SPACE; HIGH MOBILITY GROUP PROTEINS; HUMANS; IMMUNITY, INNATE; MODELS, IMMUNOLOGICAL;

EID: 74549126592     PISSN: 18749399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2009.11.002     Document Type: Review

References (116)

1. Goodwin G.H., Sanders C., and Johns E.W. A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur. J. Biochem. 38 (1973) 14-19
2. Bianchi M.E., and Agresti A. HMG proteins: dynamic players in gene regulation and differentiation. Curr. Opin. Genet. Dev. 15 (2005) 496-506
3. Hock R., Furusawa T., Ueda T., and Bustin M. HMG chromosomal proteins in development and disease. Trends Cell Biol. 17 (2007) 72-79
4. Zhou X., Benson K.F., Ashar H.R., and Chada K. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 376 (1995) 771-774
5. Caron L., Bost F., Prot M., Hofman P., and Binetruy B. A new role for the oncogenic high-mobility group A2 transcription factor in myogenesis of embryonic stem cells. Oncogene 24 (2005) 6281-6291
6. Vaccari T., Beltrame M., Ferrari S., and Bianchi M.E. Hmg4, a new member of the Hmg1/2 gene family. Genomics 49 (1998) 247-252
7. Ronfani L., Ferraguti M., Croci L., Ovitt C.E., Scholer H.R., Consalez G.G., and Bianchi M.E. Reduced fertility and spermatogenesis defects in mice lacking chromosomal protein Hmgb2. Development 128 (2001) 1265-1273
8. Nemeth M.J., Curtis D.J., Kirby M.R., Garrett-Beal L.J., Seidel N.E., Cline A.P., and Bodine D.M. Hmgb3: an HMG-box family member expressed in primitive hematopoietic cells that inhibits myeloid and B-cell differentiation. Blood 102 (2003) 1298-1306
9. Mohamed O.A., Bustin M., and Clarke H.J. High-mobility group proteins 14 and 17 maintain the timing of early embryonic development in the mouse. Dev. Biol. 229 (2001) 237-249
10. Furusawa T., Lim J.H., Catez F., Birger Y., Mackem S., and Bustin M. Down-regulation of nucleosomal binding protein HMGN1 expression during embryogenesis modulates Sox9 expression in chondrocytes. Mol. Cell. Biol. 26 (2006) 592-604
11. Muller S., Ronfani L., and Bianchi M.E. Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function. J. Intern. Med. 255 (2004) 332-343
12. Rovere-Querini P., Capobianco A., Scaffidi P., Valentinis B., Catalanotti F., Giazzon M., Dumitriu I.E., Muller S., Iannacone M., Traversari C., Bianchi M.E., and Manfredi A.A. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 5 (2004) 825-830
13. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., Frazier A., Yang H., Ivanova S., Borovikova L., Manogue K.R., Faist E., Abraham E., Andersson J., Andersson U., Molina P.E., Abumrad N.N., Sama A., and Tracey K.J. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285 (1999) 248-251
14. Bonaldi T., Talamo F., Scaffidi P., Ferrera D., Porto A., Bachi A., Rubartelli A., Agresti A., and Bianchi M.E. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 22 (2003) 5551-5560
15. Ivanov S., Dragoi A.M., Wang X., Dallacosta C., Louten J., Musco G., Sitia G., Yap G.S., Wan Y., Biron C.A., Bianchi M.E., Wang H., and Chu W.M. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 110 (2007) 1970-1981
16. Semino C., Angelini G., Poggi A., and Rubartelli A. NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood 106 (2005) 609-616
17. Lotze M.T., and Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5 (2005) 331-342
18. Feng Y., Huang N., Wu Q., and Wang B. HMGN2: a novel antimicrobial effector molecule of human mononuclear leukocytes?. J. Leukoc. Biol. 78 (2005) 1136-1141
19. Tsung A., Klune J.R., Zhang X., Jeyabalan G., Cao Z., Peng X., Stolz D.B., Geller D.A., Rosengart M.R., and Billiar T.R. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J. Exp. Med. 204 (2007) 2913-2923
20. Willingham S.B., Allen I.C., Bergstralh D.T., Brickey W.J., Huang M.T., Taxman D.J., Duncan J.A., and Ting J.P. NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways. J. Immunol. 183 (2009) 2008-2015
21. Gardella S., Andrei C., Ferrera D., Lotti L.V., Torrisi M.R., Bianchi M.E., and Rubartelli A. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 3 (2002) 995-1001
22. Oh Y.J., Youn J.H., Ji Y., Lee S.E., Lim K.J., Choi J.E., and Shin J.S. HMGB1 is phosphorylated by classical protein kinase C and is secreted by a calcium-dependent mechanism. J. Immunol. 182 (2009) 5800-5809
23. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81 (2007) 1-5
24. Andersson U., Erlandsson-Harris H., Yang H., and Tracey K.J. HMGB1 as a DNA-binding cytokine. J. Leukoc. Biol. 72 (2002) 1084-1091
25. Straino S., Di Carlo A., Mangoni A., De Mori R., Guerra L., Maurelli R., Panacchia L., Di Giacomo F., Palumbo R., Di Campli C., Uccioli L., Biglioli P., Bianchi M.E., Capogrossi M.C., and Germani A. High-mobility group box 1 protein in human and murine skin: involvement in wound healing. J. Invest. Dermatol. 128 (2008) 1545-1553
26. Janeway Jr. C.A. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13 (1992) 11-16
27. Medzhitov R., and Janeway Jr. C.A. The Toll receptor family and microbial recognition. Trends Microbiol. 8 (2000) 452-456
28. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12 (1994) 991-1045
29. Gallucci S., and Matzinger P. Danger signals: SOS to the immune system. Curr. Opin. Immunol. 13 (2001) 114-119
30. Seong S.Y., and Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4 (2004) 469-478
31. Yang D., Chertov O., Bykovskaia S.N., Chen Q., Buffo M.J., Shogan J., Anderson M., Schroder J.M., Wang J.M., Howard O.M.Z., and Oppenheim J.J. β-Defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286 (1999) 525-528
32. Yang D., Chen Q., Schmidt A.P., Anderson G.M., Wang J.M., Wooters J., Oppenheim J.J., and Chertov O. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192 (2000) 1069-1074
33. Biragyn A., Surenhu M., Yang D., Ruffini P.A., Haines B.A., Klyushnenkova E., Oppenheim J.J., and Kwak L.W. Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens. J. Immunol. 167 (2001) 6644-6653
34. Biragyn A., Ruffini P.A., Leifer C.A., Klyushnenkova E., Shakhov A., Chertov O., Shirakawa A.K., Farber J.M., Segal D.M., Oppenheim J.J., and Kwak L.W. Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science 298 (2002) 1025-1029
35. Yang D., Biragyn A., Hoover D.M., Lubkowski J., and Oppenheim J.J. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu. Rev. Immunol. 22 (2004) 181-315
36. Yang D., Rosenberg H.F., Chen Q., Dyer K.D., Kurosaka K., and Oppenheim J.J. Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells. Blood 102 (2003) 3396-3403
37. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-251
38. Yang D., and Oppenheim J.J. Antimicrobial proteins act as "alarmins" in joint immune defense. Arthritis Rheum. 50 (2004) 3401-3403
39. Oppenheim J.J., and Yang D. Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 17 (2005) 359-365
40. Scaffidi P., Misteli T., and Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418 (2002) 191-195
41. Li J., Kokkola R., Tabibzadeh S., Yang R., Ochani M., Qiang X., Harris H.E., Czura C.J., Wang H., Ulloa L., Warren H.S., Moldawer L.L., Fink M.P., Andersson U., Tracey K.J., and Yang H. Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol. Med. 9 (2003) 37-45
42. Andersson U., Wang H., Palmblad K., Aveberger A.C., Bloom O., Erlandsson-Harris H., Janson A., Kokkola R., Zhang M., Yang H., and Tracey K.J. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192 (2000) 565-570
43. Li J., Wang H., Mason J.M., Levine J., Yu M., Ulloa L., Czura C.J., Tracey K.J., and Yang H. Recombinant HMGB1 with cytokine-stimulating activity. J. Immunol. Methods 289 (2004) 211-223
44. Park J.S., Arcaroli J., Yum H.K., Yang H., Wang H., Yang K.Y., Choe K.H., Strassheim D., Pitts T.M., Tracey K.J., and Abraham E. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am. J. Physiol. Cell Physiol. 284 (2003) C870-C879
45. Pedrazzi M., Patrone M., Passalacqua M., Ranzato E., Colamassaro D., Sparatore B., Pontremoli S., and Melloni E. Selective proinflammatory activation of astrocytes by high-mobility group box 1 protein signaling. J. Immunol. 179 (2007) 8525-8532
46. Yang D., Chen Q., Yang H., Tracey K.J., Bustin M., and Oppenheim J.J. High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J. Leukoc. Biol. 81 (2007) 59-66
47. Messmer D., Yang H., Telusma G., Knoll F., Li J., Messmer B., Tracey K.J., and Chiorazzi N. High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J. Immunol. 173 (2004) 307-313
48. Telusma G., Datta S., Mihajlov I., Ma W., Li J., Yang H., Newman W., Messmer B.T., Minev B., Schmidt-Wolf I.G., Tracey K.J., Chiorazzi N., and Messmer D. Dendritic cell activating peptides induce distinct cytokine profiles. Int. Immunol. 18 (2006) 1563-1573
49. Tian J., Avalos A.M., Mao S.Y., Chen B., Senthil K., Wu H., Parroche P., Drabic S., Golenbock D., Sirois C., Hua J., An L.L., Audoly L., La Rosa G., Bierhaus A., Naworth P., Marshak-Rothstein A., Crow M.K., Fitzgerald K.A., Latz E., Kiener P.A., and Coyle A.J. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8 (2007) 487-496
50. Dumitriu I.E., Baruah P., Bianchi M.E., Manfredi A.A., and Rovere-Querini P. Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells. Eur. J. Immunol. 35 (2005) 2184-2190
51. Kokkola R., Andersson A., Mullins G., Ostberg T., Treutiger C.J., Arnold B., Nawroth P., Andersson U., Harris R.A., and Harris H.E. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand. J. Immunol. 61 (2005) 1-9
52. Hori O., Brett J., Slattery T., Cao R., Zhang J., Chen J.X., Nagashima M., Lundh E.R., Vijay S., Nitecki D., et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J. Biol. Chem. 270 (1995) 25752-25761
53. Bucciarelli L.G., Wendt T., Rong L., Lalla E., Hofmann M.A., Goova M.T., Taguchi A., Yan S.F., Yan S.D., Stern D.M., and Schmidt A.M. RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell. Mol. Life Sci. 59 (2002) 1117-1128
54. Andrassy M., Volz H.C., Igwe J.C., Funke B., Eichberger S.N., Kaya Z., Buss S., Autschbach F., Pleger S.T., Lukic I.K., Bea F., Hardt S.E., Humpert P.M., Bianchi M.E., Mairbaurl H., Nawroth P.P., Remppis A., Katus H.A., and Bierhaus A. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 117 (2008) 3216-3226
55. Park J.S., Gamboni-Robertson F., He Q., Svetkauskaite D., Kim J.Y., Strassheim D., Sohn J.W., Yamada S., Maruyama I., Banerjee A., Ishizaka A., and Abraham E. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am. J. Physiol. Cell Physiol. 290 (2006) C917-C924
56. Park J.S., Svetkauskaite D., He Q., Kim J.Y., Strassheim D., Ishizaka A., and Abraham E. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279 (2004) 7370-7377
57. Urbonaviciute V., Furnrohr B.G., Meister S., Munoz L., Heyder P., De Marchis F., Bianchi M.E., Kirschning C., Wagner H., Manfredi A.A., Kalden J.R., Schett G., Rovere-Querini P., Herrmann M., and Voll R.E. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J. Exp. Med. 205 (2008) 3007-3018
58. Huttunen H.J., Fages C., and Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274 (1999) 19919-19924
59. Akira S., and Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 4 (2004) 499-511
60. Zimmermann K., Volkel D., Pable S., Lindner T., Kramberger F., Bahrami S., and Scheiflinger F. Native versus recombinant high-mobility group B1 proteins: functional activity in vitro. Inflammation 28 (2004) 221-229
61. Rouhiainen A., Tumova S., Valmu L., Kalkkinen N., and Rauvala H. Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). J. Leukoc. Biol. 81 (2007) 49-58
62. Dintilhac A., and Bernues J. HMGB1 interacts with many apparently unrelated proteins by recognizing short amino acid sequences. J. Biol. Chem. 277 (2002) 7021-7028
63. Youn J.H., Oh Y.J., Kim E.S., Choi J.E., and Shin J.S. High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes. J. Immunol. 180 (2008) 5067-5074
64. Sha Y., Zmijewski J., Xu Z., and Abraham E. HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J. Immunol. 180 (2008) 2531-2537
65. Levy R.M., Mollen K.P., Prince J.M., Kaczorowski D.J., Vallabhaneni R., Liu S., Tracey K.J., Lotze M.T., Hackam D.J., Fink M.P., Vodovotz Y., and Billiar T.R. Systemic inflammation and remote organ injury following trauma require HMGB1. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293 (2007) R1538-R1544
66. Wu H., Chen G., Wyburn K.R., Yin J., Bertolino P., Eris J.M., Alexander S.I., Sharland A.F., and Chadban S.J. TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 117 (2007) 2847-2859
67. Kruger B., Krick S., Dhillon N., Lerner S.M., Ames S., Bromberg J.S., Lin M., Walsh L., Vella J., Fischereder M., Kramer B.K., Colvin R.B., Heeger P.S., Murphy B.T., and Schroppel B. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 3390-3395
68. Kaczorowski D.J., Nakao A., Vallabhaneni R., Mollen K.P., Sugimoto R., Kohmoto J., Zuckerbraun B.S., McCurry K.R., and Billiar T.R. Mechanisms of Toll-like receptor 4 (TLR4)-mediated inflammation after cold ischemia/reperfusion in the heart. Transplantation 87 (2009) 1455-1463
69. Liu K., Mori S., Takahashi H.K., Tomono Y., Wake H., Kanke T., Sato Y., Hiraga N., Adachi N., Yoshino T., and Nishibori M. Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J. 21 (2007) 3904-3916
70. Apetoh L., Ghiringhelli F., Tesniere A., Obeid M., Ortiz C., Criollo A., Mignot G., Maiuri M.C., Ullrich E., Saulnier P., Yang H., Amigorena S., Ryffel B., Barrat F.J., Saftig P., Levi F., Lidereau R., Nogues C., Mira J.P., Chompret A., Joulin V., Clavel-Chapelon F., Bourhis J., Andre F., Delaloge S., Tursz T., Kroemer G., and Zitvogel L. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat. Med. 13 (2007) 1050-1059
71. Tesniere A., Apetoh L., Ghiringhelli F., Joza N., Panaretakis T., Kepp O., Schlemmer F., Zitvogel L., and Kroemer G. Immunogenic cancer cell death: a key-lock paradigm. Curr. Opin. Immunol. 20 (2008) 504-511
72. Leemans J.C., Butter L.M., Pulskens W.P., Teske G.J., Claessen N., van der Poll T., and Florquin S. The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury. PLoS One 4 (2009) e5704
73. Curtin J.F., Liu N., Candolfi M., Xiong W., Assi H., Yagiz K., Edwards M.R., Michelsen K.S., Kroeger K.M., Liu C., Muhammad A.K., Clark M.C., Arditi M., Comin-Anduix B., Ribas A., Lowenstein P.R., and Castro M.G. HMGB1 mediates endogenous TLR2 activation and brain tumor regression. PLoS Med. 6 (2009) e10
74. Degryse B., Bonaldi T., Scaffidi P., Muller S., Resnati M., Sanvito F., Arrigoni G., and Bianchi M.E. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J. Cell Biol. 152 (2001) 1197-1206
75. Palumbo R., Sampaolesi M., De Marchis F., Tonlorenzi R., Colombetti S., Mondino A., Cossu G., and Bianchi M.E. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J. Cell Biol. 164 (2004) 441-449
76. Meng E., Guo Z., Wang H., Jin J., Wang J., Wu C., and Wang L. High mobility group box 1 protein inhibits the proliferation of human mesenchymal stem cells and promotes their migration and differentiation along osteoblastic pathway. Stem Cells Dev. 17 (2008) 805-813
77. Palumbo R., Galvez B.G., Pusterla T., De Marchis F., Cossu G., Marcu K.B., and Bianchi M.E. Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation. J. Cell Biol. 179 (2007) 33-40
78. Rouhiainen A., Kuja-Panula J., Wilkman E., Pakkanen J., Stenfors J., Tuominen R.K., Lepantalo M., Carpen O., Parkkinen J., and Rauvala H. Regulation of monocyte migration by amphoterin (HMGB1). Blood 104 (2004) 1174-1182
79. Campana L., Bosurgi L., Bianchi M.E., Manfredi A.A., and Rovere-Querini P. Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells. J. Leukoc. Biol. (2009)
80. Randolph G.J., Angeli V., and Swartz M.A. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev. Immunol. 5 (2005) 617-628
81. Manfredi A.A., Capobianco A., Esposito A., De Cobelli F., Canu T., Monno A., Raucci A., Sanvito F., Doglioni C., Nawroth P.P., Bierhaus A., Bianchi M.E., Rovere-Querini P., and Del Maschio A. Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes. J. Immunol. 180 (2008) 2270-2275
82. Orlova V.V., Choi E.Y., Xie C., Chavakis E., Bierhaus A., Ihanus E., Ballantyne C.M., Gahmberg C.G., Bianchi M.E., Nawroth P.P., and Chavakis T. A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J. 26 (2007) 1129-1139
83. Kaslow H.R., and Burns D.L. Pertussis toxin and target eukaryotic cells: binding, entry, and activation. FASEB J. 6 (1992) 2684-2690
84. Murphy P.M. Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev. 7 (1996) 47-64
85. Palumbo R., De Marchis F., Pusterla T., Conti A., Alessio M., and Bianchi M.E. Src family kinases are necessary for cell migration induced by extracellular HMGB1. J. Leukoc. Biol. (2009)
86. Wang H., Liao H., Ochani M., Justiniani M., Lin X., Yang L., Al-Abed Y., Metz C., Miller E.J., Tracey K.J., and Ulloa L. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 10 (2004) 1216-1221
87. Yang H., Ochani M., Li J., Qiang X., Tanovic M., Harris H.E., Susarla S.M., Ulloa L., Wang H., DiRaimo R., Czura C.J., Roth J., Warren H.S., Fink M.P., Fenton M.J., Andersson U., and Tracey K.J. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 296-301
88. Kokkola R., Sundberg E., Ulfgren A.K., Palmblad K., Li J., Wang H., Ulloa L., Yang H., Yan X.J., Furie R., Chiorazzi N., Tracey K.J., Andersson U., and Harris H.E. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum. 46 (2002) 2598-2603
89. Taniguchi N., Kawahara K., Yone K., Hashiguchi T., Yamakuchi M., Goto M., Inoue K., Yamada S., Ijiri K., Matsunaga S., Nakajima T., Komiya S., and Maruyama I. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum. 48 (2003) 971-981
90. Pullerits R., Jonsson I.M., Verdrengh M., Bokarewa M., Andersson U., Erlandsson-Harris H., and Tarkowski A. High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis. Arthritis Rheum. 48 (2003) 1693-1700
91. Popovic K., Ek M., Espinosa A., Padyukov L., Harris H.E., Wahren-Herlenius M., and Nyberg F. Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum. 52 (2005) 3639-3645
92. Jiang W., and Pisetsky D.S. Expression of high mobility group protein 1 in the sera of patients and mice with systemic lupus erythematosus. Ann. Rheum. Dis. 67 (2008) 727-728
93. Ulfgren A.K., Grundtman C., Borg K., Alexanderson H., Andersson U., Harris H.E., and Lundberg I.E. Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids. Arthritis Rheum. 50 (2004) 1586-1594
94. Yang R., Harada T., Mollen K.P., Prince J.M., Levy R.M., Englert J.A., Gallowitsch-Puerta M., Yang L., Yang H., Tracey K.J., Harbrecht B.G., Billiar T.R., and Fink M.P. Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol. Med. 12 (2006) 105-114
95. Peltz E.D., Moore E.E., Eckels P.C., Damle S.S., Tsuruta Y., Johnson J.L., Sauaia A., Silliman C.C., Banerjee A., and Abraham E. HMGB1 is markedly elevated within 6 hours of mechanical trauma in humans. Shock 32 (2009) 17-22
96. Chorny A., Anderson P., Gonzalez-Rey E., and Delgado M. Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria. J. Immunol. 180 (2008) 8369-8377
97. Dave S.H., Tilstra J.S., Matsuoka K., Li F., Demarco R.A., Beer-Stolz D., Sepulveda A.R., Fink M.P., Lotze M.T., and Plevy S.E. Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis. J. Leukoc. Biol. (2009)
98. Kikuchi K., Kawahara K., Biswas K.K., Ito T., Tancharoen S., Morimoto Y., Matsuda F., Oyama Y., Takenouchi K., Miura N., Arimura N., Nawa Y., Meng X., Shrestha B., Arimura S., Iwata M., Mera K., Sameshima H., Ohno Y., Maenosono R., Yoshida Y., Tajima Y., Uchikado H., Kuramoto T., Nakayama K., Shigemori M., Hashiguchi T., and Maruyama I. Minocycline attenuates both OGD-induced HMGB1 release and HMGB1-induced cell death in ischemic neuronal injury in PC12 cells. Biochem. Biophys. Res. Commun. 385 (2009) 132-136
99. Tang D., Kang R., Xiao W., Zhang H., Lotze M.T., Wang H., and Xiao X. Quercetin prevents lipopolysaccharide-induced HMGB1 release and proinflammatory function. Am. J. Respir. Cell Mol. Biol. (2009)
100. Zhu S., Ashok M., Li J., Li W., Yang H., Wang P., Tracey K.J., Sama A.E., and Wang H. Spermine protects mice against lethal sepsis partly by attenuating surrogate inflammatory markers. Mol. Med. 15 (2009) 275-282
101. Bell C.W., Jiang W., Reich III C.F., and Pisetsky D.S. The extracellular release of HMGB1 during apoptotic cell death. Am. J. Physiol. Cell Physiol. 291 (2006) C1318-C1325
102. Lutterloh E.C., Opal S.M., Pittman D.D., Keith Jr. J.C., Tan X.Y., Clancy B.M., Palmer H., Milarski K., Sun Y., Palardy J.E., Parejo N.A., and Kessimian N. Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection. Crit. Care 11 (2007) R122
103. Abeyama K., Stern D.M., Ito Y., Kawahara K., Yoshimoto Y., Tanaka M., Uchimura T., Ida N., Yamazaki Y., Yamada S., Yamamoto Y., Yamamoto H., Iino S., Taniguchi N., and Maruyama I. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J. Clin. Invest. 115 (2005) 1267-1274
104. Huang Y., Yin H., Han J., Huang B., Xu J., Zheng F., Tan Z., Fang M., Rui L., Chen D., Wang S., Zheng X., Wang C.Y., and Gong F. Extracellular hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection. Am. J. Transplant. 7 (2007) 799-808
105. Moser B., Szabolcs M.J., Ankersmit H.J., Lu Y., Qu W., Weinberg A., Herold K.C., and Schmidt A.M. Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation. Am. J. Transplant. 7 (2007) 293-302
106. Shaw T.J., and Martin P. Wound repair at a glance. J. Cell. Sci. 122 (2009) 3209-3213
107. Huttunen H.J., Kuja-Panula J., and Rauvala H. Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation. J. Biol. Chem. 277 (2002) 38635-38646
108. Chavakis E., Hain A., Vinci M., Carmona G., Bianchi M.E., Vajkoczy P., Zeiher A.M., Chavakis T., and Dimmeler S. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ. Res. 100 (2007) 204-212
109. Ranzato E., Patrone M., Pedrazzi M., and Burlando B. HMGb1 promotes scratch wound closure of HaCaT keratinocytes via ERK1/2 activation. Mol. Cell. Biochem. (2009)
110. Limana F., Germani A., Zacheo A., Kajstura J., Di Carlo A., Borsellino G., Leoni O., Palumbo R., Battistini L., Rastaldo R., Muller S., Pompilio G., Anversa P., Bianchi M.E., and Capogrossi M.C. Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ. Res. 97 (2005) e73-e83
111. Germani A., Limana F., and Capogrossi M.C. Pivotal advances: high-mobility group box 1 protein-a cytokine with a role in cardiac repair. J. Leukoc. Biol. 81 (2007) 41-45
112. Kazama H., Ricci J.E., Herndon J.M., Hoppe G., Green D.R., and Ferguson T.A. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 29 (2008) 21-32
113. Chen G.Y., Tang J., Zheng P., and Liu Y. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323 (2009) 1722-1725
114. Haraldsen G., Balogh J., Pollheimer J., Sponheim J., and Kuchler A.M. Interleukin-33-cytokine of dual function or novel alarmin?. Trends Immunol. 30 (2009) 227-233
115. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27 (2009) 519-550
116. Nickel W., and Rabouille C. Mechanisms of regulated unconventional protein secretion. Nat. Rev. Mol. Cell Biol. 10 (2009) 148-155